Like so many problems facing health service delivery in New Zealand, the primary driver for the proposed changes is inadequate resourcing, writes Associate Professor Ben Beaglehole ...

Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive ...

Strattera is prescribed to treat ADHD. Learn more about how long the drug takes to kick in and how long it lasts.

Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...

Dexamphetamine – a restricted stimulant drug used to treat narcolepsy and Attention Deficient Hyperactivity Disorder (ADHD) – might not be as addictive as previously thought, new research from the ...

I know firsthand what it’s like to struggle to pay for the medication I need to lead a full and healthy life. For several ...

A Maryland mom got diagnosed with a condition she didn’t know she had. Then she couldn’t afford the medicine. Now, state ...

Despite increasing awareness, identifying and mitigating the effects of ACEs remains a significant challenge, particularly ...

Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to ...

Almost three million were given ADHD drugs in the past two years, but for some they can cause more problems than they solve ...

Although stimulant dispensing rates have rebounded to — or exceeded — pre-pandemic levels among girls, the dispensing rate ...